ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2008;85:65-70. doi:10.1016/j.athoracsur.2007.06.027
© 2008 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Seung Hyuk Choi
Young Tak Lee
Sang Hoon Lee
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, J. H.
Right arrow Articles by Park, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, J. H.
Right arrow Articles by Park, J. E.
Related Collections
Right arrow Coronary disease
Right arrowRelated Article


Original Articles: Cardiovascular

Comparison of Coronary Artery Bypass Grafting With Drug-Eluting Stent Implantation for the Treatment of Multivessel Coronary Artery Disease

Jeong Hoon Yang, MD, Hyeon-Cheol Gwon, MD*, Soo Jin Cho, MD, Joo Yong Hahn, MD, Jin-Ho Choi, MD, Seung Hyuk Choi, MD, Young Tak Lee, MD, Sang Hoon Lee, MD, Kyung Pyo Hong, MD, Jeong Euy Park, MD

Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Accepted for publication June 7, 2007.

* Address correspondence to Dr Gwon, Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, 135-710, South Korea (Email: hcgwon{at}smc.samsung.co.kr).

Background: The introduction of drug-eluting stents (DESs) has demonstrated superiority over the bare metal stent in reducing the incidence of restenosis. We investigated the clinical outcomes of DESs versus coronary artery bypass grafting (CABG) in a series of patients with multivessel disease.

Methods: Patients with multivessel disease who underwent percutaneous coronary intervention with DESs (n = 441) or CABG (n = 390) between March 2003 and March 2005 were included. The primary outcomes of this study were defined as the absence of major adverse cardiac and cerebral events at 12 months, including death from any cause, cerebrovascular accidents, acute myocardial infarctions, and repeat revascularization after percutaneous coronary intervention with DESs or CABG.

Results: During 12 months of follow-up, the mortality rate was also not significantly different between the two groups (2.1% versus 3.2%, p = 0.170). The incidences of composite death, cerebrovascular accident, and acute myocardial infarction were not significantly different between groups (2.8% versus 3.9%, p = 0.180). The rate of overall major adverse cardiac and cerebral events was higher in DES group compared with the CABG group (13.0% versus 4.2%, p < 0.001), as driven by the higher incidence of myocardial infarction and revascularization.

Conclusions: The incidences of death and cerebrovascular event were not significantly different between the DES and CABG groups in the patients with multivessel disease. However, the overall incidence of major adverse cardiovascular and cerebral events seems to be favorable for CABG group even this era of DESs.


Related Article

Pitfalls Assessing the Role of Drug-Eluting Stents in Multivessel Coronary Disease
Nimesh D. Desai
Ann. Thorac. Surg. 2008 85: 25-27. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
U. Benedetto, G. Melina, E. Angeloni, S. Refice, A. Roscitano, B. Fiorani, G. D. Di Nucci, and R. Sinatra
Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24,268 patients
Eur. J. Cardiothorac. Surg., October 1, 2009; 36(4): 611 - 615.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
M. Gyongyosi, G. Christ, I. Lang, G. Kreiner, H. Sochor, P. Probst, T. Neunteufl, R. Badr-Eslam, S. Winkler, N. Nyolczas, et al.
2-Year Results of the AUTAX (Austrian Multivessel TAXUS-Stent) Registry: Beyond the SYNTAX (Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery) Study
J. Am. Coll. Cardiol. Intv., August 1, 2009; 2(8): 718 - 727.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. D. Puskas, M. E. Halkos, H. Balkhy, M. Caskey, M. Connolly, J. Crouch, A. Diegeler, J. Gummert, W. Harringer, V. Subramanian, et al.
Evaluation of the PAS-Port Proximal Anastomosis System in coronary artery bypass surgery (the EPIC trial)
J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 125 - 132.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Loponen, K. Korpilahti, M. Luther, H. Huhtala, and M. R. Tarkka
Repeat intervention after invasive treatment of coronary arteries
Eur. J. Cardiothorac. Surg., January 1, 2009; 35(1): 43 - 47.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. D. Desai
Pitfalls Assessing the Role of Drug-Eluting Stents in Multivessel Coronary Disease
Ann. Thorac. Surg., January 1, 2008; 85(1): 25 - 27.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.